Checkmate Pharmaceuticals (CMPI)
NASDAQ:CMPI
US Market
Holding CMPI?
Track your performance easily

Checkmate Pharmaceuticals (CMPI) Stock News & Sentiment

0 Followers
Checkmate Pharmaceuticals Releases Clinical Data For Vidutolimod And Pembrolizumab Combo
Premium
Market News
Checkmate Pharmaceuticals Releases Clinical Data For Vidutolimod And Pembrolizumab Combo
4y ago
Clinical-stage biotechnology company Checkmate Pharmaceuticals Inc. reported data from its Phase 1b trial evaluating the combination of vidutolimod and pembrolizumab for the treatment of advanced anti-PD-1 refractory melanoma. Checkmate Pharmaceuticals’ ...Read more

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CMPI’s Media Buzz Sentiment?
Currently, no data Available
What is CMPI’s weekly average amount of articles?
Currently, no data Available
What is CMPI’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
SWAVShockwave Medical
EIGREiger Biopharmaceuticals
ISEEIVERIC bio
NVRONevro Crop
GKOSGlaukos
Showing the stocks with the most bullish news sentiment over the past week
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis